ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

19.65
Delayed Data
As of 3:53pm ET
 -0.335 / -1.68%
Today’s Change
15.74
Today|||52-Week Range
41.20
-34.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-87.8M-67.4M-65.2M-68.9M
 
 
 
 
 
Depreciation639.0K676.0K697.0K701.0K
 
 
 
 
 
Total Other Cash Flow15.5M18.1M19.9M21.9M
 
 
 
 
 
Funds From Operations-71.7M-48.7M-44.7M-46.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.2M10.2M13.7M-16.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-70.6M-58.9M-58.4M-29.9M
 
 
 
 
 
 
InvestingIncrease In Investments-140.7M-109.3M-103.8M-125.0M
 
 
 
 
 
Decrease In Investments194.2M147.8M123.2M106.9M
 
 
 
 
 
Capital Expenditures-485.0K-264.0K-56.0K-7.0K
 
 
 
 
 
Net Cash Flow Investing52.9M38.3M19.3M-18.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale11.5M7.0M7.9M4.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing11.5M7.0M7.9M4.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.0K-3.0K-1.0K-1.0K
 
 
 
 
 
 
Net Change In Cash-6.1M-13.6M-31.2M-43.2M